LEOBENDORF, Austria, December 18, 2025--(BUSINESS WIRE)--Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for ...

LEOBENDORF, Austria--(BUSINESS WIRE)--#aestheticmedicine--Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used ...

This launch represents continued progress in Croma's mission to provide healthcare professionals state-of-the-art tools for their practice. Exprecell(TM) is now available for healthcare professionals ...

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) ...

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) ...

A new platelet-rich fibrin (PRF) matrix is becoming a promising and affordable alternative for treating chronic diabetic ulcers (diabetic foot), a pilot study conducted in São Paulo, Brazil, suggests.